BeckerJ.: Fibrinolytic activity of the blood and the relation to postoperative thrombosis of the lower limbs. Acta Chir. Scand., 138; 787–792 (1972).
2.
ChiurazziD., MozziE., SpinolaA., GerminianiR., MontorsiP.: Use of defibrotide in prophylaxis of deep vein thrombosis in general surgery. Intern. Angiol., 4; 55–56 (1985).
3.
CiavarellaN., EttorreC., SchiavoniM., SchonauerS., CicinelliE., CagnazzoG.: Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind placebo-controlled clinical trial. Haemostasis, 16; suppl. 1; 39–41 (1986).
4.
CizmeciG.: In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels. Haemostasis, 16; suppl. 1, 31–35 (1986).
5.
CoccheriS., De RosaV., DettoriA. G., PonariO., BizziB., CiavarellaN., IsidoriA.: Effect on fibrinolysis of a new antithrombotic agent: fraction P (defibrotide). A multicentre trial. Intern. J. Clin. Pharm. Res, 11; 227–245 (1982).
6.
ColditzG. A., TudenR. L., OsterG.: Rates of venous thrombosis after general surgery: combined results of randomized clinical trials. Lancet, 2; 143–146 (1986).
7.
Conference: Prevention of deep venous thrombosis and pulmonary embolism. Lancet, 1; 1202–1203 (1986).
8.
FerraraL., MoraglioD., DanieleC.: Previsione sull'andamento del decorso postoperatorio nel paziente chirurgico di età avanzata. Giorn. Gerontol, 35; 29–40 (1987).
9.
HyersT. M, HullR. D, WegJ. G.: Antithrombotic therapy for venous thromboembolic disease. Arch. Intern. Med, 146; 467 (1986).
10.
KorningerC., LechnerK., NiessnerR., GoessingerH., KundiM.: Impaired fibrinolysis capacity predisposes for recurrence of venous thrombosis. Thromb. Haemost., 52; 127–130 (1984).
11.
KrahenbuhlB., SheybaniE., BounameauxH.: Assessment of diagnosis of deep venous thrombosis of the lower limbs using estimation of clinical probability. Thromb. Haemost, 58; 382 (A 1397) (1987).
12.
McIntyreI.M.C., WebberR. G., CrispinJ. R, JonesD. R. B., WoodJ. K., AllanN. C., PrescottR. J., RuckleyC. V.: Plasma fibrinolysis and postoperative deep vein thrombosis. Brit. J. Surg, 63; 694–697 (1976).
13.
MorabiaA.: Heparin doses and major bleeding (letter). Lancet, 1; 1278–1279 (1986).
14.
NiadaR., MantovaniM., PrinoG., PescadorR., BertiF., OminiC., FolcoG.: Antithrombotic activity of a polydeoxyribonudeotidic substance extracted from mammalian organs: a possible link with prostacyclin. Thromb. Res., 23; 233–246 (1981).
15.
NiadaR., PescadorR., PortaR., MantovaniM., PrinoG.: Defibrotide is antithrombotic and thrombolytic against rabbit venous thrombosis. Haemostasis, 16; suppl. 1, 3–8 (1986).
16.
RizziA., RadaelliF., PisanoM., SortinoE., NazzariM., RattiG., GiobbeR., MaggiG.: Profilassi con defibrotide delle trombosi venose profonde in chirurgia toracica: studio multicentrico controllato verso eparina. Minerva med., 78; 745–750 (1987).
17.
RoseS. D.: Prophylaxis of thromboembolic disease. Med. Clin. N. Amer., 63; 1205–1224 (1979).
18.
SaldeenP., NilssonI. M., SaldeenT.: Increased synthesis of TxB2 and 6-Keto-PGF 1 alfa in hand vein from patients with deep vein thrombosis. Thromb. Res., 32; 461–467 (1983).
19.
SalzmanE. W., PloetzJ., BettmannM., SkillmanJ., KleinL.: Intraoperative external pneumatic calf compression to afford long term prophylaxis against deep vein thrombosis in urological patients. Surgery, 87; 239–242 (1980).
20.
TenCate H., HenryC. P., TenCate J. W., BuellerH. R., DabhoiwalaN. F.: Randomized double blind placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate. Thromb. Haemost., 57; 92–96 (1987).